Cargando…

COVID-19 – rheumatic diseases and rheumatologists

Detalles Bibliográficos
Autor principal:	Maślińska, Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2021
Materias:	Editorial Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436805/ https://www.ncbi.nlm.nih.gov/pubmed/34538938 http://dx.doi.org/10.5114/reum.2021.107429

Ejemplares similares

Rheumatologists in the COVID-19 era: will there be a new role for the rheumatologist in the care of rheumatic patients?
por: Morales-Torres, Jorge, et al.
Publicado: (2020)

The importance of physiotherapy in the sexuality of patients with rheumatic diseases
por: Żuk, Beata, et al.
Publicado: (2017)

Management of Patients With Inflammatory Rheumatic Diseases: Telemedicine and Rheumatologists Challenged in the Era of COVID-19
por: Foti, Rosario, et al.
Publicado: (2020)

COVID-19 Pandemic from Pediatric Rheumatologists Perspective
por: Demir, Selcan, et al.
Publicado: (2022)

The Third Eye of the Rheumatologist: Applications of Musculoskeletal Ultrasound in Rheumatic Diseases
por: Chen, Hsin-Hua
Publicado: (2017)

Between COVID-19 severity and its prevention – what should rheumatologists be aware of?
por: Makowska, Joanna, et al.
Publicado: (2021)

Attitude of Iraqi Rheumatologists While Managing Rheumatic Diseases in the Era of COVID-19: An Online Survey
por: Jassim, Nizar Abdulateef, et al.
Publicado: (2020)

Hepatitis E Virus and rheumatic diseases: what do rheumatologists need to know?
por: Di Bartolomeo, Salvatore, et al.
Publicado: (2020)

Public interest in rheumatic diseases and rheumatologist in the United States during the COVID-19 pandemic: evidence from Google Trends
por: Kardeş, Sinan, et al.
Publicado: (2020)

Pregnancy- and lactation-related osteoporosis: an important topic also for rheumatologists
por: Misiorowski, Waldemar
Publicado: (2023)

Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints
por: Fitzcharles, Mary-Ann, et al.
Publicado: (2014)

Attitudes of Israeli Rheumatologists to the Use of Medical Cannabis as Therapy for Rheumatic Disorders
por: Ablin, Jacob N., et al.
Publicado: (2016)

Patients’ and rheumatologists’ preferences for the attributes of biological agents used in the treatment of rheumatic diseases in Spain
por: Nolla, Joan M, et al.
Publicado: (2016)

Rheumatic fever – new diagnostic criteria
por: Szczygielska, Izabela, et al.
Publicado: (2018)

Diagnostic delays in rheumatic diseases with associated arthritis
por: Raciborski, Filip, et al.
Publicado: (2017)

Update on COVID-19 vaccines and autoimmune-mediated rheumatic diseases
por: Suresh, Lakshmanan
Publicado: (2021)

COVID-19 – Considerations for the paediatric rheumatologist
por: Hedrich, Christian M.
Publicado: (2020)

The Role of IgG4 in Autoimmunity and Rheumatic Diseases
por: Maslinska, Maria, et al.
Publicado: (2022)

Radionuclide synovectomy – essentials for rheumatologists
por: Chojnowski, Marek M., et al.
Publicado: (2016)

COVID-19: a short message to rheumatologists
por: Leszczyński, Piotr
Publicado: (2020)

What is the role of rheumatologists in the era of COVID-19?
por: Marotto, Daniela, et al.
Publicado: (2020)

How and why are rheumatologists relevant to COVID-19?
por: Felten, Renaud, et al.
Publicado: (2020)

Rheumatologists, take heart! We may be doing something right
por: van Vollenhoven, Ronald F
Publicado: (2008)

Vaccinations in rheumatic diseases
por: Szwejkowska, Martyna, et al.
Publicado: (2020)

VEXAS syndrome: an adult-onset monogenic autoinflammatory disease with many unanswered questions
por: Hernández-Rodríguez, José, et al.
Publicado: (2023)

Person-focused care for young people with rheumatic and musculoskeletal diseases: young rheumatologists' and EULAR Young PARE perspectives
por: Alunno, Alessia, et al.
Publicado: (2017)

Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology trainees
por: Tsakas, James J., et al.
Publicado: (2022)

Tuftsin-phosphorylcholine treatment of autoimmune diseases – a benefit and a message from helminths?
por: Maślińska, Maria, et al.
Publicado: (2017)

Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases
por: Richez, Christophe, et al.
Publicado: (2020)

Comorbidities and multimorbidity in rheumatic diseases
por: Filipowicz-Sosnowska, Anna
Publicado: (2019)

Early diagnosis of rheumatic diseases: an evaluation of the present situation and proposed changes
por: Kwiatkowska, Brygida, et al.
Publicado: (2015)

Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
por: Misra, Durga Prasanna, et al.
Publicado: (2020)

COVID-19: What Do Rheumatologists Need to Know?
por: Fitzgerald, Gillian E., et al.
Publicado: (2021)

Should COVID-19 take advice from rheumatologists?
por: Kernan, Kate F, et al.
Publicado: (2020)

Vaccinations in autoimmune inflammatory rheumatic diseases
por: Szenborn, Leszek
Publicado: (2016)

Panta rhei in diagnosing rheumatic diseases
por: Wiland, Piotr
Publicado: (2019)

Rheumatic and oncological diseases – common challenges
por: Jeziorski, Krzysztof
Publicado: (2017)

Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19
por: Perricone, Carlo, et al.
Publicado: (2020)

Reply to Rheumatologists’ perspective on coronavirus disease 19: is heparin the dark horse for COVID-19?
por: Ahmed, Sakir, et al.
Publicado: (2020)

How Health Information Technologies and Artificial Intelligence May Help Rheumatologists in Routine Practice
por: Foulquier, Nathan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_d8lb7fvtjj5v25he9u8ajlokvs